Flaig, T. W., Salzmann-Sullivan, M., Su, L., Zhang, Z., Joshi, M., Gijón, M. A., . . . Schlaepfer, I. R. (2017). Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade. Oncotarget.
Chicago ZitierstilFlaig, Thomas W., et al. "Lipid Catabolism Inhibition Sensitizes Prostate Cancer Cells to Antiandrogen Blockade." Oncotarget 2017.
MLA ZitierstilFlaig, Thomas W., et al. "Lipid Catabolism Inhibition Sensitizes Prostate Cancer Cells to Antiandrogen Blockade." Oncotarget 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.